Actively Recruiting
Novel Imaging Techniques for the Characterization of Musculoskeletal Tumors II
Led by Central Hospital, Nancy, France · Updated on 2020-07-21
740
Participants Needed
1
Research Sites
521 weeks
Total Duration
On this page
Sponsors
C
Central Hospital, Nancy, France
Lead Sponsor
L
Lorraine Cancer Institute - ICL
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study aims at evaluating the value of various artificial intelligence based techniques to improve the characterization and image post-processing for patients with musculoskeletal tumors.
CONDITIONS
Official Title
Novel Imaging Techniques for the Characterization of Musculoskeletal Tumors II
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients suspected to have a bone or soft-tissue tumor referred for imaging for initial tumors characterization and staging.
You will not qualify if you...
- Pregnancy
- Breast feeding patients
- Renal insufficiency
- Contra indications to MRI or CT
- Prior surgery or treatment to the evaluated lesion.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU-Nancy
Nancy, Lorraine, France, 54000
Actively Recruiting
Research Team
P
Pedro Gondim Teixieira, PhD
CONTACT
G
Gabriela Hossu, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here